Our mission is to provide comprehensive care for patients suffering from dementia, memory impairment and neurological disorders.
Our team of experienced specialists uses state-of-the-art diagnostic tools and personalized treatment plans to ensure the best possible outcomes for our patients.
From early detection and diagnostic evaluations to personalized treatment plans and ongoing support, we are committed to enhancing cognitive health and improving quality of life.
To be the leading provider of comprehensive care for dementia, memory impairment, and cognitive disorders, empowering patients to regain control of their lives through expert diagnosis, personalized treatment, and compassionate support.
Explore the critical role of specialized neurological care in preserving cognitive health and quality of life. Learn about advanced diagnostic techniques, personalized treatment plans, and the commitment to compassionate care at Memory Doctor Center. Discover how early intervention and tailored approaches can make a significant difference in managing neurological conditions.
June 5, 2026
Frontotemporal dementia (FTD) is a complex neurodegenerative disease characterized by progressive behavioral, language, and motor skill declines. Unlike Alzheimer's, FTD presents unique symptoms like personality changes, language difficulties, and motor problems, necessitating personalized diagnostic approaches. This article delves into the three main subtypes of FTD—bvFTD, svPPA, and nfvPPA—and explores genetic factors, protein abnormalities, and other risk elements contributing to its onset.
June 3, 2026
Learn about the profound impact of Lewy body dementia (LBD) on cognitive functions and daily living. This progressive neurodegenerative condition is characterized by the abnormal accumulation of proteins in the brain, leading to symptoms such as memory loss, motor difficulties, visual hallucinations, and fluctuations in attention. With an estimated 1.4 million Americans affected, LBD is one of the most prevalent forms of dementia following Alzheimer’s disease.
May 4, 2026
